Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Hemolytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04264871
What this trial is testing

Is the Preoperative Preparation of Sickle Cell Patients Optimal: Assessment of Practices and Post-operative Complications

Who this might be right for
Sickle Cell Disease
Queen Fabiola Children's University Hospital 250
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Not applicableStudy completedNCT03161899
What this trial is testing

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Who this might be right for
Thalassemia Major
Assiut University 246
Not applicableStudy completedNCT03977532
What this trial is testing

Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Assistance Publique Hopitaux De Marseille 21
Testing effectiveness (Phase 2)Study completedNCT00029393
What this trial is testing

Induction of Stable Chimerism for Sickle Cell Anemia

Who this might be right for
Blood DiseaseHematopoietic Stem Cell TransplantationAnemia, Sickle Cell
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT02447874
What this trial is testing

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 21
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Not applicableActive Not RecruitingNCT06913634
What this trial is testing

Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase

Who this might be right for
Thalassemia Major
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia 140
Not applicableEnded earlyNCT04156399
What this trial is testing

Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study

Who this might be right for
Sickle Cell Disease
University of Illinois at Chicago 6
Testing effectiveness (Phase 2)Study completedNCT01192399
What this trial is testing

Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Alexion Pharmaceuticals, Inc. 29
Not applicableStudy completedNCT04995315
What this trial is testing

Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008

Who this might be right for
Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT04380610
What this trial is testing

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

Who this might be right for
Sickle Cell DiseaseRenal DiseaseGlomerular Disease
University of Alabama at Birmingham 120
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Not applicableStudy completedNCT00960713
What this trial is testing

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

Who this might be right for
PemphigusAuto-immune Thrombocytopenic PurpuraHemolytic Auto-immune Anaemia+2 more
University Hospital, Toulouse 35
Not applicableNot Yet RecruitingNCT06743113
What this trial is testing

Hypoxic Red Blood Cells in Sickle Cell Anemia

Who this might be right for
Sickle Cell AnaemiaSickle Cell Anemia CrisisSickle Cell Anemia in Children+1 more
Hemanext 48
Not applicableUnknownNCT06098378
What this trial is testing

Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Strasbourg, France 30
Very early researchUnknownNCT05263817
What this trial is testing

A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis

Who this might be right for
POEMS SyndromeAmyloidosisAutoimmune Hemolytic Anemia+1 more
Zhejiang University 75
Not applicableStudy completedNCT05791591
What this trial is testing

Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease
LGD 168
Next Page